These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28877541)

  • 1. Ischemic Conditioning as a Hemostatic Intervention in Surgery and Cardiac Procedures: A Systematic Review.
    Krag AE; Hvas AM
    Semin Thromb Hemost; 2017 Oct; 43(7):716-731. PubMed ID: 28877541
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemostatic Complications in Hepatobiliary Surgery.
    Bos S; Bernal W; Porte RJ; Lisman T
    Semin Thromb Hemost; 2017 Oct; 43(7):732-741. PubMed ID: 28609799
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization and Effectiveness of Desmopressin Acetate After Cardiac Surgery Supplemented With Point-of-Care Hemostatic Testing: A Propensity-Score-Matched Analysis.
    Orlov D; McCluskey SA; Callum J; Rao V; Moreno J; Karkouti K
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):883-895. PubMed ID: 28169116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical implication of ischemic preconditioning in protection of reperfused tissues].
    Drozdz W; Sarwa A; Labza H
    Przegl Lek; 2006; 63(5):271-7. PubMed ID: 17036504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of ischemic preconditioning and clinical implications for multiorgan ischemic-reperfusion injury.
    Lee HT
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):78-91. PubMed ID: 10069291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombotic medication as prophylaxis of thromboembolism in surgery patients].
    Niemi T; Lassila R
    Duodecim; 2004; 120(11):1325-32. PubMed ID: 15327084
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital economic impact from hemostatic matrix usage in cardiac surgery.
    Tackett SM; Sugarman R; Kreuwel HT; Alvarez P; Nasso G
    J Med Econ; 2014 Sep; 17(9):670-6. PubMed ID: 24927164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical hemostatic agents in otolaryngologic surgery.
    Acar B; Babademez MA; Karabulut H
    Kulak Burun Bogaz Ihtis Derg; 2010; 20(2):100-9. PubMed ID: 20214554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hemostatic devices in neurosurgery. A systematic review.
    Roberto Giammalva G; Brunasso L; Costanzo R; Paolini S; Umana G; Yağmurlu K; Chaurasia B; Cicero S; Scalia G; Basile L; Maria Gerardi R; Gulì C; Angela Pino M; Graziano F; Federico Nicoletti G; Tumbiolo S; Gerardo Iacopino D; Maugeri R
    J Clin Neurosci; 2021 Jul; 89():151-157. PubMed ID: 34119260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control and treatment of hemostasis in cardiovascular surgery. The experience of La Pitié Hospital with patients on total artificial heart.
    Szefner J
    Int J Artif Organs; 1995 Oct; 18(10):633-48. PubMed ID: 8647597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the protective effect of remote ischemic preconditioning on acute kidney injury after coronary artery bypass graft surgery.
    Xue FS; Liu GP; Sun C; Li RP
    Kidney Int; 2015 Nov; 88(5):1195. PubMed ID: 26579683
    [No Abstract]   [Full Text] [Related]  

  • 12. Armentarium of topical hemostatic products in cardiovascular surgery: an update.
    Forcillo J; Perrault LP
    Transfus Apher Sci; 2014 Feb; 50(1):26-31. PubMed ID: 24412443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute kidney injury - remote ischaemic preconditioning: a nephroprotective strategy?].
    Meersch M; Zarbock A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Nov; 51(11-12):690-696. PubMed ID: 27884032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence early extubation: bleeding.
    Ammar T; Silvay G
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6 Suppl 2):28-9; discussion 41-4. PubMed ID: 9919464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protecting the heart and other organs after cardiac surgery: old problems, new solutions?
    Redington AN
    Cardiol Young; 2004 Apr; 14(2):182-91. PubMed ID: 15691408
    [No Abstract]   [Full Text] [Related]  

  • 16. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic Complications in Renal Transplantation.
    Poli D; Antonucci E; Zanazzi M
    Semin Thromb Hemost; 2017 Oct; 43(7):742-749. PubMed ID: 28609800
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specification of the development risk of thromboembolic complications in abdominal surgery].
    Shaposhnikov SA; Sin'kov SV; Zabolotskikh IB
    Vestn Khir Im I I Grek; 2013; 172(6):59-63. PubMed ID: 24738205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery.
    Fassl J; Lurati Buse G; Filipovic M; Reuthebuch O; Hampl K; Seeberger MD; Bolliger D
    Br J Anaesth; 2015 Feb; 114(2):225-34. PubMed ID: 25324348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant.
    Vecchio R; Cacciola E; Cacciola RR; Marchese S; Troina G; Intagliata E; Basile F
    Updates Surg; 2020 Dec; 72(4):1223-1227. PubMed ID: 32170631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.